Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 6
2005 7
2006 2
2007 3
2008 3
2009 1
2010 4
2011 5
2012 3
2013 6
2014 3
2015 1
2016 5
2017 6
2018 5
2019 8
2020 5
2021 9
2022 12
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease.
Klupa T, Czupryniak L, Dzida G, Fichna P, Jarosz-Chobot P, Gumprecht J, Mysliwiec M, Szadkowska A, Bomba-Opon D, Czajkowski K, Malecki MT, Zozulinska-Ziolkiewicz DA. Klupa T, et al. Among authors: czupryniak l. Diabetes Ther. 2023 Aug;14(8):1241-1266. doi: 10.1007/s13300-023-01431-3. Epub 2023 Jun 16. Diabetes Ther. 2023. PMID: 37322319 Free PMC article. Review.
Unrecognised comorbidities.
Czupryniak L, Loba J. Czupryniak L, et al. Lancet. 2005 Jan 22-28;365(9456):357. doi: 10.1016/S0140-6736(05)17793-9. Lancet. 2005. PMID: 15664234 No abstract available.
Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care.
Kalra S, Czupryniak L, Kilov G, Lamptey R, Kumar A, Unnikrishnan AG, Boudiba A, Abid M, Akanov ZA, Latheef A, Araz M, Audehm R, Bahendeka S, Balde N, Chaudhary S, Deerochanawong C, Fasanmade O, Iraqi H, Latt TS, Mbanya JC, Rodriguez-Saldana J, Hyun KS, Latif ZA, Lushchyk M, Megallaa M, Naseri MW, Bay NQ, Ramaiya K, Randeree H, Raza SA, Shaikh K, Shrestha D, Sobngwi E, Somasundaram N, Sukor N, Tan R. Kalra S, et al. Among authors: czupryniak l. Diabetes Ther. 2018 Dec;9(6):2185-2199. doi: 10.1007/s13300-018-0521-2. Epub 2018 Nov 3. Diabetes Ther. 2018. PMID: 30390228 Free PMC article. Review.
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review.
Janež A, Guja C, Mitrakou A, Lalic N, Tankova T, Czupryniak L, Tabák AG, Prazny M, Martinka E, Smircic-Duvnjak L. Janež A, et al. Among authors: czupryniak l. Diabetes Ther. 2020 Feb;11(2):387-409. doi: 10.1007/s13300-019-00743-7. Epub 2020 Jan 4. Diabetes Ther. 2020. PMID: 31902063 Free PMC article. Review.
98 results